Ziwei W. Liu

Beijing, 100730, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Efficacy and safety of romiplostim N01 for refractory aplastic anemia: a retrospective single-center study

Efficacy and safety of romiplostim N01 for refractory aplastic anemia: a retrospective single-center study

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: March 16, 2026

Selinexor in combination with azacitidine or ruxolitinib in myelodysplastic/myeloproliferative neoplasm overlap syndromes: A multicenter prospective study.

Selinexor in combination with azacitidine or ruxolitinib in myelodysplastic/myeloproliferative neoplasm overlap syndromes: A multicenter prospective study.

Journal: Cancer

Published: December 26, 2025

Efficacy and safety of lusutrombopag monotherapy for cyclosporine A-refractory, transfusion-dependent non-severe aplastic anemia

Efficacy and safety of lusutrombopag monotherapy for cyclosporine A-refractory, transfusion-dependent non-severe aplastic anemia

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: December 03, 2025

Adding recombinant human thrombopoietin to cyclosporine A and hetrombopag enhances the early hematologic response in transfusion-dependent non-severe aplastic anemia: a retrospective study.

Adding recombinant human thrombopoietin to cyclosporine A and hetrombopag enhances the early hematologic response in transfusion-dependent non-severe aplastic anemia: a retrospective study.

Journal: Hematology (Amsterdam, Netherlands)

Published: October 03, 2025

Effective treatment of refractory aplastic anemia with romiplostim after failure of multiple thrombopoietin receptor agonists: a single-center retrospective study.

Effective treatment of refractory aplastic anemia with romiplostim after failure of multiple thrombopoietin receptor agonists: a single-center retrospective study.

Journal: Annals of medicine

Published: June 19, 2025

Efficacy and safety of HRS-5965 monotherapy in complement inhibitor-naïve patients with paroxysmal nocturnal haemoglobinuria.

Efficacy and safety of HRS-5965 monotherapy in complement inhibitor-naïve patients with paroxysmal nocturnal haemoglobinuria.

Journal: British journal of haematology

Published: March 03, 2025

Eculizumab treatment for Chinese patients with hemolytic paroxysmal nocturnal hemoglobinuria (PNH): efficacy and safety - a single-center study.

Eculizumab treatment for Chinese patients with hemolytic paroxysmal nocturnal hemoglobinuria (PNH): efficacy and safety - a single-center study.

Journal: Hematology (Amsterdam, Netherlands)

Published: January 30, 2025

Long-Term Experience with Luspatercept in Relapsed/Refractory Myelodysplastic Neoplasms: A Chinese Real-World Study.

Long-Term Experience with Luspatercept in Relapsed/Refractory Myelodysplastic Neoplasms: A Chinese Real-World Study.

Journal: Advances in therapy

Published: December 15, 2024

Treatment of myelofibrosis with refractory anemia with luspatercept: a multicenter Chinese study.

Treatment of myelofibrosis with refractory anemia with luspatercept: a multicenter Chinese study.

Journal: Annals of hematology

Published: April 22, 2024

How do young surgeons understand and grasp the new concepts, new techniques, and recent progress of hernia and abdominal wall surgery?

How do young surgeons understand and grasp the new concepts, new techniques, and recent progress of hernia and abdominal wall surgery?

Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]

Published: April 23, 2023

Immunoglobulin G4-Related Disease Accompanied by Primary Myelofibrosis: Case Report.

Immunoglobulin G4-Related Disease Accompanied by Primary Myelofibrosis: Case Report.

Journal: Frontiers in medicine

Published: December 07, 2020

Showing 1-11 of 11

Last Updated: 09/26/2026